NEW YORK--(BUSINESS WIRE)-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics ...
Commenting on the results, Dr. Glicksman said, “At the mid-point of the ten-year core study, Motiva implants continue to show low rates of complication. The consistency in these clinical results is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback